Structural basis for thrombin activation of a protease-activated receptor: Inhibition of intramolecular liganding

被引:64
作者
Seeley, S
Covic, L
Jacques, SL
Sudmeier, J
Baleja, JD
Kuliopulos, A [1 ]
机构
[1] Tufts Univ, Sch Med, Div Hematol Oncol, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[3] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA
[4] Tufts Univ New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA
来源
CHEMISTRY & BIOLOGY | 2003年 / 10卷 / 11期
关键词
D O I
10.1016/j.chembiol.2003.10.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protease-activated G protein-coupled receptors (PAR1-4) are tethered-ligand receptors that are activated by proteolytic cleavage of the extracellular domain (exodomain) of the receptor. PAR1, the prototypic member of the PAR family, is the high-affinity thrombin receptor of platelets and vascular endothelium and plays a critical role in blood coagulation, thrombosis, and inflammation. Here, we describe the solution structure of the thrombin-cleaved exodomain of PAR1. The side chains of a hydrophobic hirudin-like (Hir) sequence and adjacent anionic motif project into solution. Docking of the exodomain Hir sequence to exosite I of thrombin reveals that the tethered ligand in the cleaved exodomain bends away from thrombin, leaving its active site available to another large macromolecular substrate. The N-terminal ligand is longer than anticipated and forms an intramolecular complex with a region located in the C terminus of the exodomain. Mutational analysis confirmed that this C-terminal region is a ligand binding site for both intra- and intermolecular ligands. A lipidated-ligand binding site peptide was found to be an effective inhibitor of thrombin-induced platelet aggregation.
引用
收藏
页码:1033 / 1041
页数:9
相关论文
共 51 条
  • [1] Binding of a thrombin receptor tethered ligand analogue to human platelet thrombin receptor
    Ahn, HS
    Foster, C
    Boykow, G
    Arik, L
    SmithTorhan, A
    Hesk, D
    Chatterjee, M
    [J]. MOLECULAR PHARMACOLOGY, 1997, 51 (02) : 350 - 356
  • [2] Proteinase activated receptor 2: role of extracellular loop 2 for ligand-mediated activation
    Al-Ani, B
    Saifeddine, M
    Kawabata, A
    Hollenberg, MD
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (05) : 1105 - 1113
  • [3] Andrade-Gordon P, 2001, J PHARMACOL EXP THER, V298, P34
  • [4] Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor
    Andrade-Gordon, P
    Mayanoff, BE
    Derian, CK
    Zhang, HC
    Addo, MF
    Darrow, AL
    Eckardt, AJ
    Hoekstra, WJ
    McComsey, DF
    Oksenberg, D
    Reynolds, EE
    Santulli, RJ
    Scarborough, RM
    Smith, CE
    White, KB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) : 12257 - 12262
  • [5] Molecular mapping of thrombin-receptor interactions
    Ayala, YM
    Cantwell, AM
    Rose, T
    Bush, LA
    Arosio, D
    Di Cera, E
    [J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 2001, 45 (02): : 107 - 116
  • [6] THE THROMBIN RECEPTOR EXTRACELLULAR DOMAIN CONTAINS SITES CRUCIAL FOR PEPTIDE LIGAND INDUCED ACTIVATION
    BAHOU, WF
    COLLER, BS
    POTTER, CL
    NORTON, KJ
    KUTOK, JL
    GOLIGORSKY, MS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) : 1405 - 1413
  • [7] Attacked from within, blood thins
    Bahou, WF
    [J]. NATURE MEDICINE, 2002, 8 (10) : 1082 - 1083
  • [8] IDENTIFICATION OF A NOVEL THROMBIN RECEPTOR SEQUENCE REQUIRED FOR ACTIVATION-DEPENDENT RESPONSES
    BAHOU, WF
    KUTOK, JL
    WONG, A
    POTTER, CL
    COLLER, BS
    [J]. BLOOD, 1994, 84 (12) : 4195 - 4202
  • [9] Development of potent thrombin receptor antagonist peptides
    Bernatowicz, MS
    Klimas, CE
    Hartl, KS
    Peluso, M
    Allegretto, NJ
    Seiler, SM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) : 4879 - 4887
  • [10] Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide
    Blackhart, BD
    Ruslim-Litrus, L
    Lu, CC
    Alves, VL
    Teng, W
    Scarborough, RM
    Reynolds, EE
    Oksenberg, D
    [J]. MOLECULAR PHARMACOLOGY, 2000, 58 (06) : 1178 - 1187